Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 10
Submit an article Journal homepage
175
Views
2
CrossRef citations to date
0
Altmetric
Letter

Efficacy and tolerance of dasatinib after imatinib failure or intolerance for patients with chronic myeloid leukemia treated in three different hospitals compare well with results achievable in formal clinical trials

Daniela ZackovaDepartment of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech RepublicCorrespondence[email protected]
,
Hana KlamovaInstitute of Hematology and Blood Transfusion, Prague, Czech Republic
,
Jan MuzikInstitute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic
,
Eduard CmuntGeneral University Hospital, Prague, Czech Republic
,
Zdenek RacilDepartment of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic;Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic
,
Katerina Machova PolakovaInstitute of Hematology and Blood Transfusion, Prague, Czech Republic
,
Dana DvorakovaDepartment of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic;Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic
,
Tomas JurcekDepartment of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic
,
Filip RazgaDepartment of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic
,
Petr CetkovskyInstitute of Hematology and Blood Transfusion, Prague, Czech Republic
,
Ladislav DusekInstitute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic
&
Jiri MayerDepartment of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic;Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic
 show all
Pages 2310-2313 | Received 09 Nov 2012, Accepted 28 Jan 2013, Published online: 28 Feb 2013

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Fiorenzo Santoleri, Elena Ranucci, Gaetano La Barba, Irene Colasanto, Matilde Scaldaferri, Francesco Cattel, Francesca Federici, Chiara Rossi, Katiuscia Di Biagio, Anna Rita Scortechini, Felice Musicco, Giancarlo Torquati, Angela Frazzetto, Antonietta Vozza, Caterina de Rosa, Rosaria Lanzillo, Maria Monteverde, Luigia Luciano, Fabrizio Pane, Arianna Pasquazi, Maria Grazia Celeste, Maria Cantonetti, Luca Franceschini, Manuela Rizzo & Alberto Costantini. (2021) Adherence, persistence and efficacy of dasatinib and nilotinib in the treatment of patients resistant or intolerant to imatinib with chronic myeloid leukemia in chronic phase: an Italian multicenter study over two years in real life. Current Medical Research and Opinion 37:3, pages 477-481.
Read now
Daniela Zackova, Hana Klamova, Petra Belohlavkova, Lukas Stejskal, Tereza Necasova, Lukas Semerad, Barbora Weinbergerova, Dana Srbova, Jaroslava Voglova, Petra Cicatkova, Zuzana Sustkova, Tomas Hornak, Jana Baranova, Jirina Prochazkova & Jiri Mayer. (2021) Dasatinib treatment long-term results among imatinib-resistant/intolerant patients with chronic phase chronic myeloid leukemia are favorable in daily clinical practice. Leukemia & Lymphoma 62:1, pages 194-202.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.